Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
Comparative Analysis of Clinical Outcomes and Inflammatory Responses in Viral Versus Bacterial Sepsis: A Retrospective Cohort Study in ICU Patients
Sichuan Provincial People's Hospital
300 participants
Apr 2, 2024
OBSERVATIONAL
Conditions
Summary
This observational cohort study aims to compare clinical outcomes and inflammatory responses between patients with viral sepsis, specifically COVID-19-associated sepsis, and those with bacterial sepsis. Conducted at Sichuan Provincial People's Hospital, the study will retrospectively analyze data from ICU patients admitted between July 2021 and December 2023. The primary objective is to identify reliable biomarkers and diagnostic methods to improve patient outcomes through personalized diagnostic and therapeutic strategies.
Eligibility
Inclusion Criteria5
- Patients diagnosed with sepsis according to Sepsis 3.0 criteria.
- Patients with confirmed bacterial sepsis based on positive bacterial cultures.
- Patients with confirmed viral sepsis, specifically COVID-19, diagnosed via RT-PCR for SARS-CoV-2 for viral group and negative for bacterial group.
- Patients aged 18 years and older.
- Patients admitted to the ICU during the study period.
Exclusion Criteria4
- Patients with mixed bacterial and viral infections.
- Patients with sepsis not meeting the Sepsis 3.0 criteria.
- Patients who received immunomodulatory therapies other than standard treatments (e.g., investigational drugs).
- Pregnant or breastfeeding women.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
data collected includes demographic information, clinical outcomes (mortality rate, ICU stay length), inflammatory markers (e.g., IL-2, IL-10, TNF-α), and treatment details (mechanical ventilation, CRRT, ECMO, antibiotics). Culture results, NGS findings, and imaging reports were also documented.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06491966